Delivery Order SPE2DE24D0013-SPE2D626F146P
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $1,925 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on October 21, 2025, with an ultimate completion date of October 28, 2025. The contract, designated XPRS-COV2-10, represents a delivery order for diagnostic reagents and test kits—specifically XPRS-COV2-10 cartridges for respiratory pathogen detection on the GeneXpert diagnostic platform....
- Cepheid Inc. was awarded a $4,838.52 firm fixed-price delivery order (4569983524) by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with completion expected by November 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves molecular diagnostic testing reagents and assays for the GeneXpert diagnostic platform, specifically cartridges designed to detect COVID-19, influenza, and respiratory syncytial virus. The work will be performed at Cepheid's facility...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,270.50 by the Defense Logistics Agency's Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 19, 2025. The delivery order, designated XPRSARS-COV2-10, is issued under a firm fixed-price contract structure with no set-aside designation. This award represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions,...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $10,914 on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division under the Defense Department. The firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by October 6, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents procurement...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $8,976 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on October 29, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic reagents and test kits for detection of COVID-19, influenza, and respiratory syncytial virus. This award carries no set-aside designation and represents a...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, received a $7,480 firm fixed-price delivery order from the Medical Supply Chain (Defense) on September 9, 2025, with an ultimate completion date of September 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the procurement of molecular diagnostic solutions, specifically test kits and related supplies for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F146PDelivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $5,775.00 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The delivery order, designated XPRS-COV2-10, is expected to be completed by November 20, 2025, and carries no set-aside designation. This award represents a task order issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, which carries a total ceiling value of $6.7 million through December 28, 2029. The delivery order procures XPRS-COV2-10 cartridges, which are molecular diagnostic test cartridges designed for Cepheid's GeneXpert diagnostic platform, used to detect COVID-19 and support respiratory pathogen testing across federal healthcare facilities. Cepheid has established itself as a primary federal supplier of advanced molecular diagnostic systems and reagents, serving multiple defense and civilian healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's core competency centers on providing rapid molecular diagnostic testing capabilities for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other conditions. This modest delivery order is consistent with Cepheid's extensive federal procurement portfolio, which includes comprehensive multi-million dollar agreements with the VA and numerous delivery orders across distributed medical centers and integrated service networks, all structured as firm fixed-price contracts without set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 11/13/25 |